Reduced colitis severity was also reflected in differential tissue mRNA expression: mucosal transcript levels of S100a9, Il1b and Ptgs2 were significantly reduced in DSS-induced colitis when calcineurin inhibitors were applied (Figure 3G). This evidence concerns the gene S100A9 and colitis.